Kennedy R. Lees

TL;DR: At 12 months follow-up, neurovascular thrombectomy reduced post-stroke disability and improved health-related quality of life, indicating sustained benefit, have important clinical and public health implications for evaluating the cost-effectiveness of the intervention in the long term.

TL;DR: This controlled study is the first to indicate a qualitative difference in the acute response to angiotensin converting enzyme inhibitors with similar structure and metabolism (that is, enalapril and perindopril), which seems to be less likely to cause hypotension in patients with heart failure.

TL;DR: This is the first surgical trial reporting thresholds for reduction of ICH volume correlating with improved mortality and functional outcomes, and is likely to be the first to achieve this goal.

TL;DR: Daily supplementation with folic acid, vitamin B6, and vitamin B12 to a self-selected clinical trial cohort of cognitively unimpaired patients with previous stroke or transient ischemic attack lowered mean tHcy but had no effect on the incidence of cognitive impairment or cognitive decline, as measured by the MMSE, during a median of 2.8 years.